• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE-TEX® STRETCH VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE-TEX® STRETCH VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT Back to Search Results
Model Number SBT1802D
Device Problems Adverse Event Without Identified Device or Use Problem (2993); Insufficient Information (3190)
Patient Problem Aneurysm (1708)
Event Date 11/17/2016
Event Type  Injury  
Manufacturer Narrative
As patient identifier the study- including hospital- and patient number was used.As the device remains implanted, no further investigation of the device can be performed.Further details were requested from the study coordinator, but not provided yet.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Event Description
The following was reported to gore: on (b)(6) 2016, the patient underwent surgical treatment for a protheto-femoral bypass with a gore-tex® stretch vascular graft.During surgery, there was blood loss, which required a blood transfusion.On (b)(6) 2016, a revision of the protheto-femoral anastomosis was performed.The patient was admitted to the icu and discharged to a rehabilitation center on (b)(6) 2017.Further details were requested from the study coordinator, but not provided yet.
 
Manufacturer Narrative
H1 type of reportable event must be "other".Review of new provided information from the hospital changes this event to not-reportable per our regulatory reporting guidelines, as the physician stated that there isn¿t any allegation or malfunction against the gore-tex® stretch vascular graft and that the high amount of blood loss is not related to a malfunction against the device.Also the revision of the protheto-femoral anastomosis which was performed was not related to the gore-tex® stretch vascular graft.As there is no allegation of a serious injury or malfunction of the gore-tex® stretch vascular graft in question anymore, this event is considered not reportable.The report is being retracted.
 
Event Description
The following was reported to gore: on (b)(6) 2016, the patient underwent surgical treatment for an acute ischemia with thrombosis on the deep femoral artery.A gore-tex® stretch vascular graft was implanted as aorto bifemoral bypass.During surgery, there was blood loss, which required a blood transfusion.On (b)(6) 2016, a revision of the protheto-femoral anastomosis was performed.The patient was admitted to the icu and discharged to a rehabilitation center on (b)(6) 2017.The study coordinator stated that there isn¿t any allegation or malfunction against the gore-tex® stretch vascular graft and that the blood loss is not related to a malfunction of the device.
 
Manufacturer Narrative
B5: describe event or problem : according to received information from the study coordinator the event description was updated accordingly.Furthermore the study coordinator stated that there isn¿t any allegation or malfunction against the gore-tex® stretch vascular graft and that the blood loss is not related to a malfunction of the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE-TEX® STRETCH VASCULAR GRAFT
Type of Device
PROSTHESIS, VASCULAR GRAFT
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL WEST B/P
1505 n. fourth street
flagstaff AZ 86004
Manufacturer Contact
gunter marte
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key15184704
MDR Text Key297452699
Report Number2017233-2022-03195
Device Sequence Number1
Product Code DSY
UDI-Device Identifier00733132612062
UDI-Public00733132612062
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
K904282
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study,Health Professional,User Facility
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 10/20/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/08/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/01/2021
Device Model NumberSBT1802D
Device Catalogue NumberSBT1802D
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/14/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/02/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age76 YR
Patient SexMale
-
-